It is unclear whether this reflects false negative test results related to sequencing techniques among patients who in fact have structural variants, insertions, deletions, or cryptic ALPL variants deep in intronic, promoter, or other regulatory regions, or whether alternative genes are implicated in HPP manifestations. The gene discussed is ALPL; the disease is hypophosphatasia.